UnitedHealth Group stock (US91324P1021): Morgan Stanley lifts target as shares trade near USD 398 on NYSE

UnitedHealth Group shares trade just under USD 400 on the NYSE after a fresh Morgan Stanley price target of USD 453, while investors also digest the company’s strong first-quarter 2026 results and updated valuation metrics.

UnitedHealth Group shares were changing hands at about USD 397.80 on 06/05/2026 on the New York Stock Exchange, leaving the U.S. health care heavyweight below its recent peak but above levels seen earlier this year, according to data from NYSE as of 06/05/2026.

The move comes in the wake of a new research note from Morgan Stanley, which on 06/04/2026 raised its price target on UnitedHealth Group to USD 453 from USD 395 and reiterated an overweight rating, implying mid-teens percentage upside from recent trading levels, as reported by MarketBeat citing Morgan Stanley as of 06/04/2026.

As of: 06/05/2026

By the editorial team - specialized in equity coverage.

At a glance

• Name: UnitedHealth Group
• Sector/industry: Managed care / health insurance and health services
• Headquarters/country: Minnetonka, United States
• Core markets: United States with selective international operations
• Key revenue drivers: Health benefits (UnitedHealthcare) and health services (Optum)
• Home exchange/listing venue: New York Stock Exchange (UNH)
• Trading currency: USD

UnitedHealth Group: core business model

UnitedHealth Group combines a large U.S. health insurance franchise under the UnitedHealthcare banner with the Optum health services platform, generating revenue primarily from premiums, care delivery, pharmacy benefits and data-driven health solutions.

Valuation metrics and multiples for UnitedHealth Group

Investors have been recalibrating how they value UnitedHealth Group following the release of the company’s latest quarterly report and the subsequent revision to analyst expectations. According to the firm’s first-quarter 2026 earnings release dated 04/17/2026, UnitedHealth Group reported GAAP net earnings of USD 6.13 per share and adjusted net earnings of USD 6.82 per share for the quarter ended 03/31/2026, on revenue of USD 103.5 billion, as disclosed by UnitedHealth Group Q1 2026 results as of 04/17/2026.

Based on the share price around USD 397.80 on 06/05/2026 and the annualized run rate implied by the Q1 2026 adjusted earnings figure, the stock trades on a forward-looking price-to-earnings multiple in the high-teens range, while the company has indicated a quarterly dividend of USD 2.00 per share for shareholders of record as of 06/10/2026, equating to USD 8.00 on an annualized basis, according to the dividend declaration dated 05/15/2026 from UnitedHealth Group as of 05/15/2026.

Conclusion

The combination of a higher Morgan Stanley price target, a share price around USD 397.80 on the NYSE and detailed Q1 2026 earnings and dividend metrics keeps UnitedHealth Group in focus for investors watching large U.S. health care names. The latest valuation snapshot, built on the company’s own reported figures, provides a reference point for how the market is currently pricing UnitedHealth Group’s integrated insurance and health services model.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.